• Avricore Health is making actionable health data and clinical services accessible to everyone
  • The company’s flagship holding is HealthTab™ - a company specialized in point-of-care testing solutions for pharmacy

Avricore Health Inc. (TSXV:AVCR) believes in a more accessible and proactive approach that empowers patients and improves outcomes.

The company’s flagship holding, HealthTab™,  is unlike anything in pharmacy today. It gives pharmacists a greater role in primary care delivery, while empowering patients to take more control of their health. The device also reduces costs and waiting times, provides many potential revenue streams including equipment leasing & consumables and disease prevention & management programs, and enables third-party app integration through API.

In August 2022, Avricore announced a Master Agreement to expand the HealthTab™ platform for diabetes management in up to 450 Shoppers Drug Mart locations, plus the Real Canadian Superstore based Pharmacist Walk-In Clinics.

HealthTab already has positive cash-flow from operations and is expected to significantly ramp up gross revenues over the next 12 months yielding target margins and profitability by Q2 2023.

One of the winners in this year’s TSX Venture 50, the company is on track to creating the world’s largest network of rapid testing devices in community pharmacies.


Learn how Avricore Health Inc. is moving pharmacy forward here.

Make sure to follow Avricore Health to see their latest updates:





The 2023 TSX Venture 50 is a ranking of top performers on TSX Venture Exchange over the last year. The ranking is composed of 10 companies from each of the five industry sectors and are selected based on three equally weighted criteria: market capitalization growth, share price appreciation and trading volume.

For the full 2023 TSX Venture 50 ranking, methodology and profile videos of companies included in the ranking, visit: www.tsx.com/venture50